Related Experiment Video
Updated: Aug 29, 2026

Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery
Published on: March 28, 2025
Prevention of gallstones by ursodeoxycholic acid after cardiac surgery
Toshiji Ai1, Ryosaku Azemoto, Hiromitsu Saisho
1Division of Gastroenterology, Chiba Cardiovascular Center, 575 Tsurumai, 290-0512, Ichihara, Japan.
Insights
Ursodeoxycholic acid (UDCA) effectively prevents gallstone formation in patients undergoing open cardiac surgery. Prophylactic UDCA significantly reduced gallstone incidence over 60 months in this study.
Area of Science:
- Cardiology
- Gastroenterology
- Surgical Innovation
Background:
- Gallstone formation is a known complication in patients with prosthetic heart valves.
- The use of cardiopulmonary bypass (heart-lung machine) during cardiac surgery is suspected to contribute to gallstone development.
- Ursodeoxycholic acid (UDCA) is investigated for its potential to prevent gallstones post-cardiac surgery.
Purpose of the Study:
- To evaluate the efficacy of ursodeoxycholic acid (UDCA) in preventing gallstone formation after open cardiac surgery.
- To assess the long-term impact of UDCA prophylaxis on gallstone incidence in cardiac surgery patients.
Main Methods:
- A randomized controlled trial involving 106 patients undergoing cardiac surgery with a heart-lung machine.
- Patients were divided into two groups: one receiving UDCA (600 mg daily for 6 months) and a control group.
- Ultrasonography monitored gallstone formation for 60 months, with blood markers of hemolysis assessed at various intervals.
Main Results:
- The cumulative incidence of gallstones was significantly lower in the UDCA group (0-8.4%) compared to the control group (15.1-29.2%) over 60 months.
- No gallstones were observed in the UDCA group at 3 and 6 months post-surgery.
- The gallstones formed in the control group were primarily black pigment stones.
Conclusions:
- Prophylactic administration of ursodeoxycholic acid (UDCA) significantly reduces the incidence of gallstones following open cardiac surgery.
- UDCA appears to be an effective preventive measure against gallstone formation in this patient population.
- The findings support the use of UDCA to mitigate a common post-surgical complication.
Background:
One of the problems in prosthetic-valve recipients is the development of gallstones. We suggested that the use of a heart-lung machine may be closely related to gallstone formation. The objective of this study was to clarify the efficacy of ursodeoxycholic acid (UDCA) in the prevention of gallstone formation after open cardiac surgery.
Methods:
One hundred and six patients without gallstones who underwent cardiac surgery in which a heart-lung machine was used were randomly divided into two groups: group A, comprising 54 patients who did not receive UDCA, and group B, comprising 52 patients who received UDCA (600 mg daily for 6 months from 1 week before surgery). Both groups were followed by ultrasonography for 60 months. Blood markers of hemolysis (hemoglobin, reticulocyte count, haptoglobin, total bilirubin, and lactate dehydrogenase) were evaluated before, immediately after, and at 3 weeks and 3, 6, 12, 24, and 60 months after surgery.
Results:
In groups A and B, cumulative incidence rates for gallstone formation were 15.1% and 0% at 3 months, 23.0% and 0% at 6 months, 29.2% and 2.0% at 12 months, 29.2% and 8.4% at 24 months, and 29.2% and 8.4% at 60 months, respectively. In regard to the composition of the gallstones, they were considered to be mainly black pigment stones.
Conclusions:
The prophylactic administration of UDCA resulted in a significant decrease in the incidence of gallstones after open cardiac surgery.
Related Concept Videos
Cholecystitis
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Coronary Artery Disease IV: Preventive Measures
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...